An Emerging Role for Anti-inflammatory Agents for Chemoprevention
There have been a number of promising recent developments in the prevention of colorectal cancer. This book examines in detail important aspects of the current status of and future prospects for chemoprevention of colorectal tumors, particularly using anti-inflammatory drugs. Research into the mechanisms that lead from early colorectal adenoma to colorectal cancer is discussed. The role and modes of action of available anti-inflammatory drugs, such as aspirin, celecoxib, and sulindac are described and recent data from trials of aspirin are reviewed. In addition, the possible impact of nutritional agents with anti-inflammatory properties is considered, and strategies applicable in those with a high level of genetic risk are evaluated. An important feature of the book is its interdisciplinary perspective, offering highly relevant information for gastroenterologists, internists, general practitioners, oncologists, colorectal and gastroenterological surgeons, and public health practitioners.
KeywordsFamilial Adenomatous Polyposis Fecal Occult Blood Testing Colorectal Adenoma Adenomatous Polyp Chemopreventive Agent
- Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet].Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.fr, accessed on 02/02/2011
- Schror K (2009) Acetylsalicyclic acid. Blackwell, GermanyGoogle Scholar
- Vane JR (1982) Adventures and excursions in bioassay: the stepping stones to prostaglandins. Nobel lecture, 8 December PMID 6360277Google Scholar